Red Tree Management, LLC

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 22, 2026), Red Tree Management, LLC reported 3 stock positions worth $147.3 million. Its top holding was Bicara Therapeutics (BCAX) at 63.8% of the portfolio, followed by Ceribell (CBLL, 29.1%) and Contineum Therapeutics Class A (CTNM, 7.1%). Compared with Q1 2026, it reduced 1. The biggest sale was Bicara Therapeutics (BCAX, shares −0%).

Most Recent 13F
Q2 2026
Location
REDWOOD CITY, CA
CIK
0002055980
Portfolio Value
$147.3M (Q2 2026)
SEC Filing
0002055980-26-000008 ↗ filed Jul 22, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q4 2024: $152.0M Q4 2024 Q1 2025: $92.6M Q1 2025 Q2 2025: $73.3M Q2 2025 Q3 2025: $82.9M Q3 2025 Q4 2025: $109.0M Q4 2025 Q1 2026: $111.8M Q1 2026 Q2 2026: $147.3M $147.3M Q2 2026

Holdings 3 stocks · $147.3M
BCAX Bicara Therapeutics Inc. 63.77% 3,163,517 $93.9M Reduce -0.2%
CBLL Ceribell Inc. 29.13% 2,205,661 $42.9M No change
CTNM Contineum Therapeutics Inc. Class A 7.10% 638,158 $10.5M No change

Portfolio Sells Q1 2026 → Q2 2026
BCAX Bicara Therapeutics Inc. Reduce -0.2% 63.77% +7.38

Portfolio Buys Q1 2026 → Q2 2026
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$147.3MBCAX, CBLL, CTNM
Q1 2026 3$111.8MBCAX, CBLL, CTNM
Q4 2025 3$109.0MBCAX, CBLL, CTNM
Q3 2025 3$82.9MBCAX, CBLL, CTNM
Q2 2025 3$73.3MCBLL, BCAX, CTNM
Q1 2025 4$92.6MCBLL, BCAX, CRGX, CTNM
Q4 2024 4$152.0MCBLL, BCAX, CRGX, CTNM